Re: "i would think FDA approval will speak for itself. And not $3.00, i am thinking alot more."
Other shareholders and I are suggesting CTGI should probably be near $3.00 now, before FDA approval (as nellio73 says), just on strength of what CSMG has going for it. We are, of course, concerned about dilution if co. must raise more private capital at lower stock prices. Company arguably spending a lot of money these days. For example, in order to feed itself, CSMG privately sold 1,347,766 shs @ ave $0.615--a 38% discount to closing ave market price of $.995. This on 17/18 Oct 2007. A lower stock price base also delimits upside once FDA approval lever is tripped.
These are my opinions and sentiments only. Take them for what they're worth. Do your DD. Buying stocks is risky!
"If we could sell our experiences for what they cost us, we'd all be millionaires." -Abigail van Buren (a/k/a Dear Abby)